FDA Cleared Handheld Cardiac Implant Identifier

BridgeSource Medical received clearance for a device that identifies cardiac implants in emergency settings.

Updated on Oct. 8, 2026 in Heart Disease

Isometric editorial illustration of a metallic handheld medical scanner beside a stylized cardiac implant on a clinical table. — The FDA has granted de novo clearance to Austin-based BridgeSource Medical for a handheld scanner designed to identify cardiac pacemakers and defibrillators in emergency settings. AI Illustration. Upload story photo >

Live Poll

Is emergency medical care for patients with cardiac implants getting better in your area?

The FDA has granted de novo clearance to Austin-based BridgeSource Medical for a handheld scanner that identifies cardiac pacemakers and defibrillators. The system is designed to help medical staff quickly determine device brands in emergency rooms.

Why it matters

Patients often arrive in emergency departments unable to provide details about their implanted devices, which is critical for proper triage and treatment. Having a tool to identify hardware ensures clinicians use the correct protocols for specific manufacturers.

The scanner identifies devices from manufacturers including Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort in 20 seconds. The development was supported by $3 million in funding from the National Institute on Aging.

The players

BridgeSource Medical

An Austin, Texas-based medical technology company focused on developing diagnostic tools for cardiovascular care.

National Institute on Aging

A federal agency that supports research into aging and health challenges for older adults.

The details

The handheld device mimics communication pings normally sent by manufacturer programming wands to elicit a brand response from the implant. Healthcare workers use the scanner directly on the patient to detect the manufacturer without needing patient input.

The FDA granted clearance for the identifier on October 8, 2026.

Health Landscape

This diagnostic tool follows a pattern set by the National Institute on Aging's commercialization readiness funding, which prioritizes technologies that address the health vulnerabilities of the elderly. It marks a shift toward standardizing emergency responses for a growing population of patients with complex implanted devices.

For patients with pacemakers or defibrillators, this technology reduces the risk of incorrect treatment during an emergency. It simplifies the triage process for clinicians, potentially saving time when every second counts for an incapacitated patient.

The takeaway

This technology highlights how specialized diagnostic tools can bridge critical information gaps in acute care environments. Patients with implants should continue to keep their medical information updated and readily available to emergency responders.